Armata Pharmaceuticals, Inc.股价拉升11.21% 市值涨523.24万美元

市场透视2025-04-15

北京时间2025年04月15日21时40分，Armata Pharmaceuticals, Inc.（ARMP.us）股票出现波动，股价大幅拉升11.21%。截至发稿，该股报1.29美元/股，成交量4248股，换手率0.01%，振幅2.59%。最近的财报数据显示，该股实现营业收入5.17百万美元，净利润-18.92百万美元，每股收益-0.52美元，毛利3.85百万美元，市盈率-1.45倍。机构评级...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2527417819?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-04-15 21:40","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2527417819","market":"us","top_or_hot":-1,"title":"Armata Pharmaceuticals, Inc.股价拉升11.21% 市值涨523.24万美元","media":"市场透视","content":"<div>\n<p>北京时间2025年04月15日21时40分，Armata Pharmaceuticals, Inc.（ARMP.us）股票出现波动，股价大幅拉升11.21%。截至发稿，该股报1.29美元/股，成交量4248股，换手率0.01%，振幅2.59%。最近的财报数据显示，该股实现营业收入5.17百万美元，净利润-18.92百万美元，每股收益-0.52美元，毛利3.85百万美元，市盈率-1.45倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415214001a459c79f&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Armata Pharmaceuticals, Inc.股价拉升11.21% 市值涨523.24万美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nArmata Pharmaceuticals, Inc.股价拉升11.21% 市值涨523.24万美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-04-15 21:40 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415214001a459c79f&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年04月15日21时40分，Armata Pharmaceuticals, Inc.（ARMP.us）股票出现波动，股价大幅拉升11.21%。截至发稿，该股报1.29美元/股，成交量4248股，换手率0.01%，振幅2.59%。最近的财报数据显示，该股实现营业收入5.17百万美元，净利润-18.92百万美元，每股收益-0.52美元，毛利3.85百万美元，市盈率-1.45倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415214001a459c79f&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415214001a459c79f&s=b","article_id":"2527417819","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415214001a459c79f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2527417819","pubTimestamp":1744724401,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年04月15日21时40分，Armata Pharmaceuticals, Inc.股票出现波动，股价大幅拉升11.21%。Armata Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。Armata Pharmaceuticals, Inc.公司简介：Armata Pharmaceuticals Inc 是一家病原体特异性噬菌体疗法的开发商，利用其专有的噬菌体技术来治疗抗生素耐药性和难以治疗的细菌感染。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","ARMP":"Armata Pharmaceuticals, Inc."},"translate_title":"Armata Pharmaceuticals, Inc. Stock Rises 11.21%, Market Cap Rises $5.2324 Million","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ARMP":1},"content_text":"北京时间2025年04月15日21时40分，Armata Pharmaceuticals, Inc.（ARMP.us）股票出现波动，股价大幅拉升11.21%。截至发稿，该股报1.29美元/股，成交量4248股，换手率0.01%，振幅2.59%。最近的财报数据显示，该股实现营业收入5.17百万美元，净利润-18.92百万美元，每股收益-0.52美元，毛利3.85百万美元，市盈率-1.45倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Armata Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Mural Oncology Plc、Verve Therapeutics, Inc.、Nextcure, Inc.涨幅较大，Mural Oncology Plc、Metavia Inc.、Plus Therapeutics, Inc.较为活跃，换手率分别为465.50%、209.39%、82.59%，振幅较大的相关个股有60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 (To Pur Com)、Mural Oncology Plc、Nextcure, Inc.，振幅分别为80.08%、52.43%、38.78%。Armata Pharmaceuticals, Inc.公司简介：Armata Pharmaceuticals Inc 是一家病原体特异性噬菌体疗法的开发商，利用其专有的噬菌体技术来治疗抗生素耐药性和难以治疗的细菌感染。该公司正在开发和推进一系列天然和合成噬菌体候选药物，包括铜绿假单胞菌、金黄色葡萄球菌和其他病原体的临床候选药物。此外，该公司正在与默克合作，开发专有的合成噬菌体候选物，以针对未公开的传染病病原体。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2527417819","isCrawlerRequest":true}